Clinical Usefulness of Serum Prostate Specific Antigen for the Detection of Prostate Cancer is Preserved in Men Receiving the Dual 5α-Reductase Inhibitor Dutasteride-Reference-Cited by-同舟云学术

Clinical Usefulness of Serum Prostate Specific Antigen for the Detection of Prostate Cancer is Preserved in Men Receiving the Dual 5α-Reductase Inhibitor Dutasteride

Published:2006-05 Issue:5 Volume:175 Page:1657-1662
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Andriole Gerald L.¹,Marberger Michael²,Roehrborn Claus G.³

Affiliation:

1. Division of Urologic Surgery, Washington University, St. Louis, Missouri

2. Department of Urology, University of Vienna, Vienna, Austria

3. Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference18 articles.

1. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen;Cooner;J Urol,1990

2. Screening decreases prostate cancer death;Labrie;Prostate,1999

3. Prostate-specific antigen change in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam;Raaijmakers;Urology,2004

4. Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer;Roobol;Urology,2004

5. Selectivity of finasteride as an in vivo inhibitor of 5 alpha-reductase isozyme enzymatic activity in the human prostate;Span;J Urol,1999

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate‐specific antigen density during dutasteride treatment for 1 year predicts the presence of prostate cancer in benign prostatic hyperplasia after the first negative biopsy (PREDICT study);International Journal of Urology;2021-05-18

2. Deciphering the binding of dutasteride with human alpha-2-macroglobulin: Molecular docking and calorimetric approach;International Journal of Biological Macromolecules;2019-07

3. Continued 5α-Reductase Inhibitor Use after Prostate Cancer Diagnosis and the Risk of Reclassification and Adverse Pathological Outcomes in the PASS;Journal of Urology;2019-01

4. The effect of 3-month finasteride challenge on biomarkers for predicting cancer outcome on biopsy: Results of a randomized trial;PLOS ONE;2018-10-09

5. Prostate cancer prevention;Cancer Prevention and Screening;2018-08-14